Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Training nursing home staff to improve residents' end-of-life care: design and baseline findings from a randomized controlled trial.

European geriatric medicine

Lamppu PJ, Laurila J, Finne-Soveri H, Laakkonen ML, Kautiainen H, Pitkälä KH.
PMID: 34652735
Eur Geriatr Med. 2019 Aug;10(4):649-657. doi: 10.1007/s41999-019-00200-5. Epub 2019 May 21.

PURPOSE: We aim to describe the design, educational intervention, baseline findings and feasibility of our training intervention. Our trial will aim to improve the residents' health-related quality of life (HRQOL) and to reduce unnecessary hospitalizations.METHODS: We recruited 340 residents...

Cite
Lamppu PJ, Laurila J, Finne-Soveri H, et al. Training nursing home staff to improve residents' end-of-life care: design and baseline findings from a randomized controlled trial. Eur Geriatr Med. 2019;10(4):649-657doi: 10.1007/s41999-019-00200-5.
Lamppu, P. J., Laurila, J., Finne-Soveri, H., Laakkonen, M. L., Kautiainen, H., & Pitkälä, K. H. (2019). Training nursing home staff to improve residents' end-of-life care: design and baseline findings from a randomized controlled trial. European geriatric medicine, 10(4), 649-657. https://doi.org/10.1007/s41999-019-00200-5
Lamppu, Pauli J, et al. "Training nursing home staff to improve residents' end-of-life care: design and baseline findings from a randomized controlled trial." European geriatric medicine vol. 10,4 (2019): 649-657. doi: https://doi.org/10.1007/s41999-019-00200-5
Lamppu PJ, Laurila J, Finne-Soveri H, Laakkonen ML, Kautiainen H, Pitkälä KH. Training nursing home staff to improve residents' end-of-life care: design and baseline findings from a randomized controlled trial. Eur Geriatr Med. 2019 Aug;10(4):649-657. doi: 10.1007/s41999-019-00200-5. Epub 2019 May 21. PMID: 34652735.
Copy Download .nbib Format: NLM
Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation.

Cellular and molecular life sciences : CMLS

Iftakhar-E-Khuda I, Pessia A, Zheng S, Kankainen M, Kontro M, Karikoski M, Laurila J, Gerke H, Tadayon S, Hollmén M, Tang J, Imhof BA, Salmi M, Jalkanen S.
PMID: 34719737
Cell Mol Life Sci. 2021 Dec;78(23):7851-7872. doi: 10.1007/s00018-021-03977-6. Epub 2021 Nov 01.

Although the development of hematopoietic stem cells (HSC) has been studied in great detail, their heterogeneity and relationships to different cell lineages remain incompletely understood. Moreover, the role of Vascular Adhesion Protein-1 in bone marrow hematopoiesis has remained unknown....

Cite
Iftakhar-E-Khuda I, Pessia A, Zheng S, et al. Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation. Cell Mol Life Sci. 2021;78(23):7851-7872doi: 10.1007/s00018-021-03977-6.
Iftakhar-E-Khuda, I., Pessia, A., Zheng, S., Kankainen, M., Kontro, M., Karikoski, M., Laurila, J., Gerke, H., Tadayon, S., Hollmén, M., Tang, J., Imhof, B. A., Salmi, M., & Jalkanen, S. (2021). Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation. Cellular and molecular life sciences : CMLS, 78(23), 7851-7872. https://doi.org/10.1007/s00018-021-03977-6
Iftakhar-E-Khuda, Imtiaz, et al. "Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation." Cellular and molecular life sciences : CMLS vol. 78,23 (2021): 7851-7872. doi: https://doi.org/10.1007/s00018-021-03977-6
Iftakhar-E-Khuda I, Pessia A, Zheng S, Kankainen M, Kontro M, Karikoski M, Laurila J, Gerke H, Tadayon S, Hollmén M, Tang J, Imhof BA, Salmi M, Jalkanen S. Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation. Cell Mol Life Sci. 2021 Dec;78(23):7851-7872. doi: 10.1007/s00018-021-03977-6. Epub 2021 Nov 01. PMID: 34719737.
Copy Download .nbib Format: NLM
Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris.

Clinical drug investigation

Melcher A, Abelin J, Luurila O.
PMID: 18370494
Clin Drug Investig. 1998;15(5):389-96. doi: 10.2165/00044011-199815050-00003.

A randomised, double-blind, placebo-controlled, parallel-group trial with forced titration study to investigate possible equivalence of efficacy and tolerability between nisoldipine coat-core (CC) 40mg once daily, and diltiazem retard 120mg twice daily, was carried out in 176 patients with stable...

Cite
Melcher A, Abelin J, Luurila O. Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris. Clin Drug Investig. 1998;15(5):389-96doi: 10.2165/00044011-199815050-00003.
Melcher, A., Abelin, J., & Luurila, O. (1998). Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris. Clinical drug investigation, 15(5), 389-96. https://doi.org/10.2165/00044011-199815050-00003
Melcher, A, et al. "Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris." Clinical drug investigation vol. 15,5 (1998): 389-96. doi: https://doi.org/10.2165/00044011-199815050-00003
Melcher A, Abelin J, Luurila O. Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris. Clin Drug Investig. 1998;15(5):389-96. doi: 10.2165/00044011-199815050-00003. PMID: 18370494.
Copy Download .nbib Format: NLM
[Not Available].

Duodecim; laaketieteellinen aikakauskirja

Strandberg T, Laurila J.
PMID: 17091677
Duodecim. 2006;122(12):1472-4.

No abstract available.

Cite
Strandberg T, Laurila J. Miten emme vanhenisi? [Not Available]. Duodecim. 2006;122(12):1472-4
Strandberg, T., & Laurila, J. (2006). Miten emme vanhenisi? [Not Available]. Duodecim; laaketieteellinen aikakauskirja, 122(12), 1472-4.
Strandberg, Timo, and Laurila, Jouko. "Miten emme vanhenisi?" [Not Available]. Duodecim; laaketieteellinen aikakauskirja vol. 122,12 (2006): 1472-4.
Strandberg T, Laurila J. Miten emme vanhenisi? [Not Available]. Duodecim. 2006;122(12):1472-4. Finnish. PMID: 17091677.
Copy Download .nbib Format: NLM
Cost-effectiveness of Percutaneous Transluminal Angioplasty (PTA) Versus Vascular Surgery in Limb-threatening Ischaemia.

The International journal of angiology : official publication of the International College of Angiology, Inc

Laurila J, Brommels M, Standertskjöld-Nordenstam CG, Leinonen S, Lepäntalo M, Edgren J, Suramo I.
PMID: 11062310
Int J Angiol. 2000 Oct;9(4):214-219. doi: 10.1007/BF01623897.

The purpose of this study was to analyze the cost and cost-effectiveness of femoropopliteal PTA compared to femoropopliteal bypass surgery in chronic critical ischaemia of the lower limb. A total of 772 patients were treated either by femoropopliteal PTA...

Cite
Laurila J, Brommels M, Standertskjöld-Nordenstam CG, et al. Cost-effectiveness of Percutaneous Transluminal Angioplasty (PTA) Versus Vascular Surgery in Limb-threatening Ischaemia. Int J Angiol. 2000;9(4):214-219doi: 10.1007/BF01623897.
Laurila, J., Brommels, M., Standertskjöld-Nordenstam, C. G., Leinonen, S., Lepäntalo, M., Edgren, J., & Suramo, I. (2000). Cost-effectiveness of Percutaneous Transluminal Angioplasty (PTA) Versus Vascular Surgery in Limb-threatening Ischaemia. The International journal of angiology : official publication of the International College of Angiology, Inc, 9(4), 214-219. https://doi.org/10.1007/BF01623897
Laurila, et al. "Cost-effectiveness of Percutaneous Transluminal Angioplasty (PTA) Versus Vascular Surgery in Limb-threatening Ischaemia." The International journal of angiology : official publication of the International College of Angiology, Inc vol. 9,4 (2000): 214-219. doi: https://doi.org/10.1007/BF01623897
Laurila J, Brommels M, Standertskjöld-Nordenstam CG, Leinonen S, Lepäntalo M, Edgren J, Suramo I. Cost-effectiveness of Percutaneous Transluminal Angioplasty (PTA) Versus Vascular Surgery in Limb-threatening Ischaemia. Int J Angiol. 2000 Oct;9(4):214-219. doi: 10.1007/BF01623897. PMID: 11062310.
Copy Download .nbib Format: NLM
Severity of both neuropsychiatric symptoms and dementia is associated with quality of life in nursing home residents.

European geriatric medicine

Roitto HM, Kautiainen H, Laurila J, Pitkälä KH.
PMID: 34652697
Eur Geriatr Med. 2019 Oct;10(5):793-800. doi: 10.1007/s41999-019-00213-0. Epub 2019 Jul 05.

PURPOSE: The primary focus in long-term care is to maintain quality of life. The aim of this study was to investigate the association of severity of neuropsychiatric symptoms (NPS) and health-related quality of life (HRQoL) and their interaction with...

Cite
Roitto HM, Kautiainen H, Laurila J, et al. Severity of both neuropsychiatric symptoms and dementia is associated with quality of life in nursing home residents. Eur Geriatr Med. 2019;10(5):793-800doi: 10.1007/s41999-019-00213-0.
Roitto, H. M., Kautiainen, H., Laurila, J., & Pitkälä, K. H. (2019). Severity of both neuropsychiatric symptoms and dementia is associated with quality of life in nursing home residents. European geriatric medicine, 10(5), 793-800. https://doi.org/10.1007/s41999-019-00213-0
Roitto, Hanna-Maria, et al. "Severity of both neuropsychiatric symptoms and dementia is associated with quality of life in nursing home residents." European geriatric medicine vol. 10,5 (2019): 793-800. doi: https://doi.org/10.1007/s41999-019-00213-0
Roitto HM, Kautiainen H, Laurila J, Pitkälä KH. Severity of both neuropsychiatric symptoms and dementia is associated with quality of life in nursing home residents. Eur Geriatr Med. 2019 Oct;10(5):793-800. doi: 10.1007/s41999-019-00213-0. Epub 2019 Jul 05. PMID: 34652697.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries